Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment

This publication has 46 references indexed in Scilit:

• 5′ UTR polymorphism of dopamine receptor D1 (DRD1) associated with severity and temperament of alcoholism
  Biochemical and Biophysical Research Communications, 2007
• Association of an Asn40Asp (A118G) polymorphism in the μ-opioid receptor gene with substance dependence: A meta-analysis
  Drug and Alcohol Dependence, 2006
• Polymorphism of μ-Opioid Receptor Gene (OPRM1:c.118A>G ) Does Not Protect Against Opioid-induced Respiratory Depression despite Reduced Analgesic Response
  Anesthesiology, 2005
• Pharmacogenetics and Human Molecular Genetics of Opiate and Cocaine Addictions and Their Treatments
  Pharmacological Reviews, 2005
• The 118 A > G polymorphism in the human µ‐opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease
  Acta Anaesthesiologica Scandinavica, 2004
• Effect of the A118G polymorphism on binding affinity, potency and agonist‐mediated endocytosis, desensitization, and resensitization of the human mu‐opioid receptor
  Journal of Neurochemistry, 2004
• Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor
  Human Molecular Genetics, 2003
• Relationship of the delta‐opioid receptor gene to heroin abuse in a large Chinese case/control sample
  American Journal of Medical Genetics, 2002
• Interindividual Variability of the Clinical Pharmacokinetics of Methadone
  Clinical Pharmacokinetics, 2002
• μ opioid receptor gene variants: lack of association with alcohol dependence
  Molecular Psychiatry, 1997